Rocket Lab and AST SpaceMobile Rally 8% as Space Stocks Rebound; SpaceX Holds Steady

Rocket Lab (RKLB) and AST SpaceMobile (ASTS) shares rose 8% as space stocks rebounded. Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, with a record backlog of $3.57B. AST SpaceMobile missed sales expectations but remains focused on future network plans. SpaceX (SPCX) shares were relatively unchanged. Both companies face execution risks and losses.

Original reporting
Published Nov 11, 2026, 4:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 4:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rocket Lab and AST SpaceMobile Rally 8% as Space Stocks Rebound; SpaceX Holds Steady — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

Earnings beats and strong backlog for Rocket Lab drive immediate buying, whereas AST's miss is offset by a short‑term rebound, indicating divergent trader reactions within the space sector.

02

Market read

The earnings releases provide fresh data for traders to position in the space sector, with immediate upside potential for RKLB and a short‑term rally opportunity for ASTS.

03

What to watch

AST SpaceMobile's upcoming Blacklift rocket and network rollout timeline remain uncertain and could cap upside.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Both Rocket Lab and AST SpaceMobile released their Q3 2026 earnings, sparking a sector‑wide rally among smaller space stocks while SpaceX remained flat.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

Rocket Lab reported record Q3 revenue of $267.8M and a $3.57B backlog, driving an 8% pre‑market rally.

Expected impact

likely upward pressure as investors price in record revenue and guidance

Evidence & confidence

Revenue beat and backlog growth outweigh loss and dilution concerns in the short term.

$ASTSNeutralMedium confidence
Context

AST SpaceMobile posted Q3 sales of $42.32M, missing consensus, but its stock rose 8% on rebound after the miss.

Expected impact

potential modest upside as the rebound may attract short‑term traders

Evidence & confidence

Sales miss limits upside, but the 8% rally shows buying interest despite YTD decline.

Market effects

Strong Rocket Lab results may lift sentiment across small‑cap space launch firms.

U.S. tech and growth‑oriented investors may see increased exposure to space equities.

Limited to investors tracking the niche space launch sector.

Counterpoint

The sizable net loss and dilution from the Iridium deal could weigh on Rocket Lab longer term.

Key entities

  • Rocket Lab

    U.S. listed launch provider (NASDAQ:RKLB) reporting record Q3 revenue.

  • AST SpaceMobile

    U.S. listed satellite‑network firm (NASDAQ:ASTS) reporting Q3 sales miss but price rebound.

Related articles

$LUNRHighAI 8/10

Intuitive Machines Surges 16% on Record Quarter and Positive Free Cash Flow; AST SpaceMobile Falls 3%, Rocket Lab Slips 2%

Intuitive Machines (LUNR) surged 16% after reporting Q3 2026 revenue of $269.35M, beating estimates and growing 413.7% YoY. The company generated $33M in free cash flow and secured a $1.87B backlog. CEO Steve Altemus highlighted record financial performance. Despite gains, the core business remains unprofitable. AST SpaceMobile (ASTS) and Rocket Lab (RKLB) fell 3% and 2%, respectively, amid broader growth stock declines.

$RKLBMed

Could Rocket Lab Actually Climb 56%? Or Is Morgan Stanley Totally Wrong?

Morgan Stanley reduced its price target for Rocket Lab to $103, 56% above its Nov. 11 close of $66.15, while maintaining an Overweight rating. The company sold $2.4B in stock Q3 and delayed Neutron's first launch to 2027. Analysts expect 3 cents EPS for 2027, down from 16 cents a year ago. Rocket Lab reported record revenue of $268M, up 73%, but a wider GAAP loss of 12 cents per share.

$RKLBMedAI 8/10

$8 Billion Merger Stuck at FCC: SpaceX Accuses Iridium of Using Spectrum Objections to Block Starlink Ground Stations — BigGo Finance

Rocket Lab's $8B acquisition of Iridium Communications faces FCC review opposition from SpaceX, which claims Iridium's spectrum objections are anticompetitive. The deal, valued at $54 per share, is expected to close in 2027. SpaceX seeks to include Iridium's spectrum behavior in the FCC's public-interest assessment, while Rocket Lab and Iridium argue the merger is pro-competitive. The FCC must decide whether to consider spectrum disputes in merger reviews.

$RKLBHighAI 8/10

Rocket Lab CEO Says It Could Be ‘Extremely Profitable’ Without Neutron — But SpaceX Is Not The Only Reason It’s Building The Rocket

Rocket Lab CEO Peter Beck sees a $1 trillion market in space services, beyond the $10-20 billion launch market. The company's proposed $8 billion acquisition of Iridium Communications (IRDM) is expected to close in mid-2027. Neutron rocket's debut is delayed to 2027, with 16 flights booked, including 8 worth $515 million. RKLB stock is down 5% year-to-date, with mixed retail sentiment.

$RKLBMed

Rocket Lab Lands $150M OSC Loan Pledge for Neutron Rocket

Rocket Lab USA secured a conditional $150M loan from the Department of War's Office of Strategic Capital for its reusable Neutron rocket. Funds will expand production and add recovery vessels. The loan is subject to due diligence and other conditions. Neutron is designed to carry 13,000 kg to low Earth orbit, supporting satellite constellations and national security payloads. This is OSC's third $150M space-sector commitment.

$RKLBHighAI 8/10

Rocket Lab posts $268 million quarter, expects Neutron in 2027

Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, exceeding forecasts. Net loss widened to $79.7M, with adjusted EBITDA at -$18.0M. Space systems revenue grew 88% to $214.8M. Neutron rocket's launch delayed to 2027 due to manufacturing issues. Backlog reached $3.57B, with $1B in new launch contracts. Iridium acquisition pending regulatory approval, expected to close in 2027.